Serial NT-proBNP assays could potentially identify which of those without clinical disease might most benefit from heart-failure preventive therapies, researchers propose.
/PRNewswire/ KBP Biosciences PTE. Ltd. ("KBP Biosciences" or the "Company"), a clinical-stage biotechnology company dedicated to research, development, and.